What the blood–brain barrier is — and how it affects brain cancer treatment

TL;DR

• The blood–brain barrier protects the brain from harmful substances.
• It also blocks many cancer drugs from reaching brain tumors.
• New treatments and trials are designed to cross or bypass this barrier safely.

What the Blood–Brain Barrier Is — and How It Affects Brain Cancer Treatment

Treating brain cancer isn't just about reaching the tumor — it's about getting past the brain's built-in defense system.

That system is called the blood–brain barrier, and its job is to protect the brain from harmful substances circulating in the bloodstream. While this protection is essential for brain health, it also creates major challenges for treating brain tumors.

How the Blood–Brain Barrier Works

The blood–brain barrier acts like a tightly sealed filter around the brain. It is made up of specialized blood vessels and cells that carefully control what can pass from the bloodstream into brain tissue.

This barrier allows essential substances — such as oxygen and nutrients — to enter the brain, while blocking most drugs, toxins, and even many immune cells. As a result, treatments that work well for cancers elsewhere in the body may have difficulty reaching brain tumors in effective amounts.

Because of this, simply identifying a promising cancer drug is often not enough — researchers must also determine whether it can successfully cross the blood–brain barrier.

Why the Blood–Brain Barrier Matters in Brain Cancer

In brain cancer, the blood–brain barrier can limit how well standard treatments work. Even after surgery or radiation, drug therapies may struggle to penetrate remaining tumor cells protected by this barrier.

To address this challenge, researchers are developing new strategies, including modified drug designs, targeted therapies, and novel delivery methods that can safely cross or bypass the blood–brain barrier. Some approaches temporarily open the barrier, while others are engineered to pass through it without causing harm. You can read more about drug delivery across the blood-brain barrier in cancer therapy in Nature Reviews Cancer.

Exploring Blood–Brain Barrier–Focused Trials With PACT AI

More clinical trials are now focused on therapies designed specifically to overcome the blood–brain barrier — not just attack the tumor itself.

PACT AI helps patients and caregivers stay informed about these emerging approaches by tracking trials built for the unique realities of brain cancer. Our goal is to make it easier to understand how new treatments work and to help you explore options designed to reach where brain tumors actually live.

Learn more about how PACT AI can help →

Have questions? Reach out at contact@pact-ai.com.